This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Academisch Ziekenhuis Maastricht, Medtronic, Inc., University of Maastricht. Active years: 2019.
Company Filing History:
1 out of 28 
1 out of 8,950 
1 out of 45 
Years Active: 2019
Title: Kevin Vernooy: Innovator in Cardiac Resynchronization Therapy
Introduction
Kevin Vernooy is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of cardiac resynchronization therapy (CRT). His innovative approach focuses on improving the delivery of CRT through advanced electrogram-based control mechanisms.
Latest Patents
Kevin Vernooy holds a patent for "Electrogram-based control of cardiac resynchronization therapy." This patent describes a method for controlling the delivery of CRT by adjusting ventricular pacing according to various values of A-V delay or V-V delay. The process involves acquiring electrograms from different vectors and determining QRS amplitude or area based on these electrograms. By identifying target changes in QRS amplitude or area, the implantable medical device can optimize ventricular pacing to enhance CRT effectiveness.
Career Highlights
Throughout his career, Kevin has worked with prominent organizations, including Medtronic, Inc. and Universiteit Maastricht. His experience in these institutions has allowed him to develop and refine his innovative ideas in the medical technology sector.
Collaborations
Kevin has collaborated with several professionals in his field, including Elien B Engels and Alfonso Aranda Hernandez. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Kevin Vernooy is a pioneering inventor whose work in cardiac resynchronization therapy has the potential to significantly improve patient outcomes. His dedication to innovation in medical technology continues to inspire advancements in the field.